PROCEPT BioRobotics officer to sell 373 shares

PROCEPT BioRobotics Corp (PRCT) has a notice under Rule 144 indicating that officer Kevin Waters may sell up to 373 shares of the company’s common stock through Fidelity Brokerage Services LLC on NASDAQ.

Available on EDGAR 09/09/2026 - 03:12 PM EDT Accepted by SEC EDGAR 09/09/2026 - 03:12 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) has a notice under Rule 144 indicating that officer Kevin Waters may sell up to 373 shares of the company’s common stock through Fidelity Brokerage Services LLC on NASDAQ.

The shares relate to restricted stock that vested on September 8, 2026, and the planned sale includes an amount to cover a tax obligation arising from the settlement of this vested equity award.

Key Figures

Shares covered by Rule 144 notice: 373 shares Planned sale date: September 9, 2026 Restricted stock vesting date: September 8, 2026

3 metrics

Shares covered by Rule 144 notice 373 shares Maximum number of PROCEPT BioRobotics common shares to be sold for Kevin Waters’ account

Planned sale date September 9, 2026 Approximate date of sale for the shares covered by the notice

Restricted stock vesting date September 8, 2026 Date the restricted stock underlying the planned sale vested as compensation

Key Terms

Rule 144, Restricted Stock Vesting, vested equity award, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 09/08/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award financial

"resulting from the settlement of a vested equity award distribution"

attorney-in-fact regulatory

"as attorney-in-fact for Kevin Waters"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 notice for PRCT disclose about Kevin Waters’ planned sale?

The notice shows that officer Kevin Waters may sell up to 373 shares of PROCEPT BioRobotics common stock under Rule 144, with sales to be executed through Fidelity Brokerage Services LLC on NASDAQ.

How many PRCT shares are covered by Kevin Waters’ Rule 144 notice?

The Rule 144 notice covers up to 373 shares of PROCEPT BioRobotics Corp common stock. These shares are tied to restricted stock that vested on September 8, 2026.

Why is Kevin Waters selling PRCT shares according to the Rule 144 notice?

According to the remarks, the sale of PRCT shares includes an amount necessary to cover a tax obligation that arose from the settlement of a vested equity award distribution.

What is the source of the PRCT shares Kevin Waters plans to sell?

The shares come from restricted stock vesting on September 8, 2026, related to a compensation award from PROCEPT BioRobotics Corp.

Which broker and exchange are involved in the PRCT Rule 144 sale for Kevin Waters?

The planned Rule 144 sale for Kevin Waters’ PRCT shares is through Fidelity Brokerage Services LLC, with the common stock listed for trading on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001653771
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCEPT BioRobotics Corp
SEC File Number	001-40797
Address of Issuer	150 BAYTECH DRIVE SAN JOSE CALIFORNIA 95134
Phone	6502329832
Name of Person for Whose Account the Securities are To Be Sold	Waters Kevin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	373	7815.54	57273659	09/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Restricted Stock Vesting	Issuer			373	09/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin Waters
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)